Ozempic often used off-label) Tirzepatide (Zepbound / Mounjaro) a dual GLP-1/GIP agonist that tends to produce even greater weight loss Liraglutide (Saxenda) Originally developed for Type 2 diabetes, these medications received Health Canada approval for chronic weight management in adults with a BMI 30, or BMI 27 with at least one weight-related condition (such as hypertension, dyslipidemia, or obstructive sleep apnea)
Tirzepatide, meanwhile, combines the effects of both GLP-1 and GIP receptor agonists, offering dual action that may further enhance appetite suppression and metabolic benefits
TSA allows liquid medications in quantities exceeding the 3.4-ounce limit when declared at the security checkpoint
However, semaglutide is over two times more effective than liraglutide in causing weight loss, says Kushner
Altogether, these factors contribute to treatment inefficiency and patient dissatisfaction